UNSPSC 51384510: Indoprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CPE46ZU14N, chemically known as 4-(1,3-dihydro-1-oxo-2h-isoindol-2-yl)-alpha-methylbenzeneacetic acid but generally known as indoprofen, which bears US NIH Compound Identifier 3718. European Medicines Agency schedules Indoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08183MIG.

UNSPSC 51384510 Indoprofen, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS posted June 30, 2026—solicits naloxone and drug deactivation systems for community health use, a scope entirely outside the pharmaceutical anti-inflammatory drug category that the code nominally describes. No recent state and local opportunities reflect actual procurement of indoprofen or related pharmaceutical commodities.

The mismatch between code and solicitation suggests either a tagging error in the source system or that this Commodity code sees no active state and local buying activity at present. Without additional opportunities tagged under UNSPSC 51384510 that reflect its stated scope, no reliable assessment of issuing-body mix, geographic concentration, or market activity under the code is possible. Business development professionals should verify whether indoprofen procurement falls under a different UNSPSC designation or whether state and local purchasing in this category remains inactive.